New research from Warwick Medical School indicates some of your risk of developing obesity, diabetes and heart conditions is pre-determined whilst in the womb and by improving the pregnant mother’s diet and vitamins intake you can shape your baby’s future metabolism for the better.
Revealing the findings at Warwick Medical School’s International Symposium on Human Metabolism Research (10 & 11 November), Dr Ponnusamy Saravanan, Associate Clinical Professor in Diabetes, Endocrine & Metabolism at the University of Warwick, explained:
“We are, without doubt, facing an obesity epidemic in this country. With each generation we are becoming more overweight and developing more cases of associated conditions such as diabetes and heart disease.
“This research, done in collaboration with the University of Southampton and the Kind Edward Memorial Hospital, in Pune, India, examines pregnant women and follows the growth and development of their babies. We have found that mothers with low vitamin B12 gave birth to babies with features suggestive of them developing diabetes and cardiovascular diseases soon after birth and at 6 years.
“We believe that the micro-nutrients (vitamins) in a woman’s diet fundamentally influence how the DNA functions, and this gene-diet interaction determines, at least in part, whether you are going to be more prone to being overweight as an adult. So this very early ‘in-utero’ stage can be critical in mapping out your adult health. Warwick’s research on the functions of fat cells (adipocytes), indeed shows such imbalance of micronutrients fundamentally affects how energy is handled by these cells.”
Dr Saravanan concluded: “Our research is still ongoing, with a further phase beginning early next year, but all the indications show that we need to establish more ‘primordial prevention’ which means taking preventive action before these conditions develop, to improve our nation’s future health and reduce the cost of treatment for the NHS.”
The International Symposium for Advances in Human Metabolism Research is being held at the University of Warwick on 10 and 11 November. Hosted by the University’s Professor Sudhesh Kumar, expert speakers in metabolism from around the world including Boston, Denmark, Sweden and Singapore, have been invited to debate the challenges we face in tackling obesity and will showcase the new £1.9m Human Metabolism Research Unit (HMRU) based at University Hospital in Coventry.
The HMRU will enhance Warwick’s ability and capacity to conduct world-class research into metabolism and the conditions associated with obesity.
Dr Ponnusamy Saravanan is Associate Clinical Professor & Honorary Consultant Physician in Diabetes, Endocrine & Metabolism at Warwick Medical School within the University of Warwick and George Eliot Hospital. For further information or to interview Dr Saravanan, contact Kate Cox, Communications Manager on +44 (0)2476 574255/150483, m: +44(0)7920 531221 or email@example.com.
For more information about the HMRU see: http://www2.warwick.ac.uk/fac/med/research/platform/hmru/
This state-of-the-art facility was funded by University Hospitals Coventry & Warwickshire NHS Trust and Warwick Medical School through the Science City Research Alliance (SCRA) which is part of a long-term research programme between the University of Warwick and the University of Birmingham. SCRA, which is funded by HEFCE, is part of a larger investment by Advantage West Midlands and ERDF in the research infrastructure of the West Midlands region, through Birmingham Science City.
Birmingham Science City is a region-wide partnership of public sector, businesses and the research base, which is facilitating the use of science and technology to improve the quality of life and prosperity of the West Midlands. Currently funded by Birmingham City Council and the Universities of Birmingham and Warwick Birmingham Science City’s aim is to create strategies to exploit centres of world-class scientific research, by developing relevant activities for sustainable economic and social benefit.